Stay updated on AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.

Latest updates to the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded site revision banner "Revision: v3.4.2" and removed the previous "Revision: v3.4.1" banner (along with the funding-status notice). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center operations was added, and the page version updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedAdded a glossary toggle and small UI changes, including capitalization tweaks and a new revision tag (Revision: v3.4.0). No changes to study content, eligibility criteria, or key results were observed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3 on the page, which appears to be a minor site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a consolidated Locations section listing trial sites in Maryland, Missouri, North Carolina, Tennessee, Texas, Wisconsin, and Ontario, and updated the page revision to v3.3.3. The previous per-location subsections and the HHS Vulnerability Disclosure section were removed.SummaryDifference0.7%

- Check85 days agoChange DetectedRevision: v3.3.2 shown; no other content changes are evident.SummaryDifference0.0%

Stay in the know with updates to AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AZD8701 & Durvalumab in Advanced Solid Tumours Clinical Trial page.